Insurance Coverage for Emerging Diabetes Technologies: Payers' Perspective

Advances in glucose monitoring and insulin delivery technologies have led to the development of innovative self-management tools, such as continuous glucose monitoring, automated insulin delivery systems, and smart connected insulin pens. Although the clinical advantages of today's emerging dia...

Full description

Saved in:
Bibliographic Details
Published inDiabetes technology & therapeutics Vol. 23; no. S3; p. S28
Main Authors Nolan, Tim, Frazzitta, Marie
Format Journal Article
LanguageEnglish
Published United States 01.09.2021
Subjects
Blood Glucose
Blood Glucose Self-Monitoring
Diabetes Mellitus - therapy
Humans
Insulin Infusion Systems
Insurance Coverage
Continuous glucose monitoring
Diabetes
Cost
Insurance
Risk stratification
Online AccessGet full text
ISSN1520-9156
1557-8593
1557-8593
DOI10.1089/dia.2021.0262

Cover

More Information
Summary:Advances in glucose monitoring and insulin delivery technologies have led to the development of innovative self-management tools, such as continuous glucose monitoring, automated insulin delivery systems, and smart connected insulin pens. Although the clinical advantages of today's emerging diabetes technologies are well documented, the cost of integrating these tools into clinical practice must be considered to sustain the financial viability of both public and private insurers. Most clinicians are unfamiliar with the process the commercial insurers follow when making these decisions. This article reviews the key factors the insurers consider when determining eligibility criteria.
ISSN:1520-9156
1557-8593
1557-8593
DOI:10.1089/dia.2021.0262